{"hands_on_practices": [{"introduction": "One of the first questions in functional genomics is \"Where and when is a gene turned on?\". Reporter gene assays provide a powerful visual answer by linking a gene's regulatory DNA, its promoter, to a visible marker like Green Fluorescent Protein (GFP). This practice challenges you to interpret the results of such a hypothetical experiment, a fundamental skill for deciphering a gene's potential role within an organism. [@problem_id:1489242]", "problem": "In a functional genomics study, researchers are investigating a newly discovered gene, referred to as *gene_X*, in the nematode *Caenorhabditis elegans*. To determine the gene's expression pattern, they construct a piece of synthetic DNA. This construct consists of the promoter region isolated from *gene_X* fused directly to the coding sequence for Green Fluorescent Protein (GFP), a protein that glows green under specific wavelengths of light. This synthetic DNA is then introduced into *C. elegans* embryos, creating transgenic worms.\n\nAfter the worms develop into adults, the researchers observe them using a fluorescence microscope. They find that green fluorescence is exclusively visible in the neurons of the worms, with no fluorescence detected in other cell types like muscle or intestinal cells.\n\nBased *only* on the results of this specific experiment, which of the following is the most accurate conclusion?\n\nA. The promoter of *gene_X* is active in neuronal cells, leading to transcription of its associated gene in those cells.\n\nB. The protein product of *gene_X* is localized and functions only within neuronal cells.\n\nC. *gene_X* is essential for the proper development and survival of neurons.\n\nD. The Green Fluorescent Protein (GFP) is naturally synthesized by *C. elegans* neurons.\n\nE. The full coding sequence of *gene_X* is translated into a functional protein within neuronal cells.", "solution": "The experimental construct is a reporter in which only the promoter region of gene_X is fused upstream of the GFP coding sequence. The relevant molecular principle is that a promoter drives transcription of any downstream coding sequence in cells where the promoter is active. In this setup, transcription from the gene_X promoter produces GFP mRNA in cells where the promoter is active, and translation yields GFP protein, whose fluorescence under excitation indicates promoter activity.\n\nObservation: Fluorescence is seen exclusively in neurons. This indicates that the gene_X promoter is active in neuronal cells and not detectably active in other tested cell types under the conditions of the experiment.\n\nEvaluation of options:\n- A is directly supported: the promoter drives transcription in neurons, evidenced by GFP expression.\n- B is not supported: the coding sequence of gene_X is not present in the reporter; thus protein localization or function of gene_X cannot be inferred.\n- C is not supported: essentiality requires loss-of-function analysis; this experiment is only expression reporting.\n- D is false: GFP is not endogenous to C. elegans; fluorescence arises from the transgene.\n- E is false: the full coding sequence of gene_X is not present; only GFP is translated.\n\nTherefore, the most accurate conclusion based only on this experiment is A.", "answer": "$$\\boxed{A}$$", "id": "1489242"}, {"introduction": "Once we know where a gene is expressed, we often want to understand its function in a biological process, such as a metabolic pathway. By creating mutations and observing whether supplying a chemical intermediate can \"rescue\" the defect, we can logically order genes in a pathway. This classic genetic problem-solving technique, known as supplementation analysis, allows us to piece together the steps of a biological assembly line based on experimental evidence. [@problem_id:1489231]", "problem": "A team of geneticists is investigating the biochemical pathway responsible for producing a crucial blue-colored anti-fungal compound in the bacterium *Streptomyces caeruleus*. The wild-type strain is blue. Through mutagenesis, they isolate two different single-gene, loss-of-function mutant strains, which they name *mutA* and *mutB*. Both *mutA* and *mutB* strains are unable to produce the blue compound and form colorless colonies.\n\nThe researchers hypothesize that the genes corresponding to these mutations, *geneA* and *geneB*, encode enzymes in a linear metabolic pathway. They manage to isolate a stable, colorless intermediate molecule from the pathway, which they call Compound X. To determine the functional order of the genes, they perform a supplementation experiment by growing each mutant strain on a medium containing Compound X.\n\nThe experimental results are as follows:\n1.  The *mutA* strain, when grown on a medium supplemented with Compound X, produces the blue compound and forms blue colonies.\n2.  The *mutB* strain, when grown on the same medium supplemented with Compound X, remains colorless.\n\nAssuming *geneA* and *geneB* are part of a simple linear pathway converting a precursor to the final blue compound, which of the following statements correctly describes their functional order?\n\nA. *geneA* and *geneB* function in parallel pathways that are both required to synthesize the blue compound.\n\nB. *geneB* acts before *geneA* in the pathway.\n\nC. *geneA* acts before *geneB* in the pathway.\n\nD. *geneA* is a regulatory gene that positively controls the expression of *geneB*.\n\nE. *geneB* is a regulatory gene that positively controls the expression of *geneA*.", "solution": "We assume a simple linear biosynthetic pathway and the one-gene-one-enzyme principle: each gene encodes an enzyme that catalyzes one step. Let $P$ be the precursor and $F$ the final blue compound. The experiment identifies a stable, colorless intermediate $X$. There are two possible linear orders for the enzymes encoded by geneA and geneB relative to $X$:\n$$\n\\text{Order 1: } P \\xrightarrow{\\text{A}} X \\xrightarrow{\\text{B}} F\n$$\n$$\n\\text{Order 2: } P \\xrightarrow{\\text{B}} X \\xrightarrow{\\text{A}} F\n$$\n\nWe now use supplementation logic: adding $X$ should rescue a mutant that is blocked at a step upstream of $X$, because the pathway can proceed from $X$ onward. Conversely, adding $X$ will not rescue a mutant blocked at a step downstream of $X$, because the supplemented metabolite still requires the defective downstream step to reach $F$.\n\nTest Order 1:\n- In a mutA strain (loss of A), the step $P \\to X$ is blocked, so no $X$ or $F$ is produced. Supplementing with $X$ bypasses A, enabling $X \\xrightarrow{\\text{B}} F$, so the phenotype becomes blue. This matches observation 1.\n- In a mutB strain (loss of B), the step $X \\to F$ is blocked. Supplementing with $X$ does not restore $X \\to F$, so the phenotype remains colorless. This matches observation 2.\n\nTest Order 2:\n- In a mutA strain (loss of A), the step $X \\to F$ is blocked. Supplementing with $X$ would not rescue, predicting colorless colonies, which contradicts observation 1.\n- In a mutB strain (loss of B), the step $P \\to X$ is blocked. Supplementing with $X$ would rescue by allowing $X \\xrightarrow{\\text{A}} F$, predicting blue colonies, which contradicts observation 2.\n\nTherefore, only Order 1 is consistent with the data, so geneA acts before geneB in the pathway, with $X$ being the product of the geneA-catalyzed reaction and the substrate for the geneB-catalyzed reaction. Parallel pathways (option A) or regulatory explanations (options D and E) are unnecessary and inconsistent with metabolite rescue patterns, which specifically diagnose enzymatic step order in a linear pathway.\n\nThus, the correct choice is that geneA acts before geneB.", "answer": "$$\\boxed{C}$$", "id": "1489231"}, {"introduction": "Genetic variation in promoter regions can lead to differences in gene expression levels, which can have significant biological consequences. To move beyond simply visualizing expression, we use quantitative reporter assays, such as the luciferase assay, to precisely measure promoter strength. This exercise asks you to analyze hypothetical experimental data to quantify the functional difference between two promoter alleles, linking a change in DNA sequence to a measurable change in regulatory activity. [@problem_id:1489206]", "problem": "A researcher is investigating the genetic basis of metabolic adaptation in a specific human cell line. They focus on a gene named *Glycolysis Upregulator 7* (*GU7*), which is critical for shifting cellular energy production. Using RNA-sequencing (RNA-seq), they analyze a cell line that is heterozygous for the *GU7* gene, possessing one 'fast' allele (Allele F) and one 'slow' allele (Allele S). The sequencing data reveals significant Allele-Specific Expression (ASE), indicating a differential rate of transcription between the two alleles.\n\nTo test the hypothesis that this ASE is caused by a difference in a *cis*-regulatory element within the gene's promoter, the researcher designs a reporter gene assay. Two plasmid constructs are created. The first construct, `pGL-F`, contains the promoter sequence isolated from Allele F placed upstream of a luciferase reporter gene. The second construct, `pGL-S`, contains the promoter sequence from Allele S placed upstream of the same luciferase gene. A third control plasmid, `pGL-Empty`, contains the luciferase gene but lacks any promoter sequence.\n\nThese plasmids are independently transfected into separate, identical batches of the human cell line. After an incubation period to allow for gene expression, the cells are lysed, and luminescence is measured. The results, reported in Relative Light Units (RLU), are as follows:\n-   Cells transfected with `pGL-F`: $8.761 \\times 10^5$ RLU\n-   Cells transfected with `pGL-S`: $2.452 \\times 10^5$ RLU\n-   Cells transfected with `pGL-Empty`: $1.830 \\times 10^4$ RLU\n\nAssuming transfection efficiency and plasmid concentration were identical for all experiments, calculate the ratio of the transcriptional activity of the Allele F promoter to that of the Allele S promoter. Report your answer as a single numerical value, rounded to three significant figures.", "solution": "The goal of this problem is to determine the relative strength of two different promoter alleles using data from a luciferase reporter assay. The core principle is that the measured luminescence is directly proportional to the amount of luciferase enzyme produced, which in turn is proportional to the transcriptional activity driven by the promoter cloned into the reporter plasmid.\n\nFirst, we must account for the background luminescence. The `pGL-Empty` plasmid contains the luciferase gene but no promoter. Any light produced by cells transfected with this plasmid represents background signal, which could be due to non-specific transcription or inherent properties of the assay reagents and the plate reader. This background must be subtracted from the measurements of the experimental constructs (`pGL-F` and `pGL-S`) to find the true promoter-driven activity.\n\nLet $L_F$ be the luminescence from the `pGL-F` construct, $L_S$ be the luminescence from the `pGL-S` construct, and $L_{Empty}$ be the background luminescence from the `pGL-Empty` construct. The given values are:\n$L_F = 8.761 \\times 10^5$ RLU\n$L_S = 2.452 \\times 10^5$ RLU\n$L_{Empty} = 1.830 \\times 10^4$ RLU\n\nThe corrected transcriptional activity for the Allele F promoter, let's call it $A_F$, is the measured luminescence minus the background luminescence.\n$$A_F = L_F - L_{Empty}$$\n$$A_F = (8.761 \\times 10^5) - (1.830 \\times 10^4)$$\nTo perform the subtraction, we can express both numbers with the same power of 10.\n$1.830 \\times 10^4 = 0.1830 \\times 10^5$.\n$$A_F = (8.761 - 0.1830) \\times 10^5 = 8.578 \\times 10^5 \\text{ RLU}$$\n\nSimilarly, the corrected transcriptional activity for the Allele S promoter, $A_S$, is calculated by subtracting the same background.\n$$A_S = L_S - L_{Empty}$$\n$$A_S = (2.452 \\times 10^5) - (1.830 \\times 10^4)$$\n$$A_S = (2.452 - 0.1830) \\times 10^5 = 2.269 \\times 10^5 \\text{ RLU}$$\n\nThe problem asks for the ratio of the transcriptional activity of the Allele F promoter to that of the Allele S promoter. This ratio, $R$, is given by:\n$$R = \\frac{A_F}{A_S}$$\n$$R = \\frac{8.578 \\times 10^5 \\text{ RLU}}{2.269 \\times 10^5 \\text{ RLU}}$$\nThe units (RLU) and the factor of $10^5$ cancel out.\n$$R = \\frac{8.578}{2.269}$$\nNow we perform the division:\n$$R \\approx 3.779638607$$\n\nThe problem requires the final answer to be rounded to three significant figures. The first three significant figures are 3, 7, and 7. The fourth digit is 9, which is 5 or greater, so we round up the third digit.\n$$R \\approx 3.78$$\n\nThis result indicates that the promoter from Allele F is approximately 3.78 times more active than the promoter from Allele S under these experimental conditions, which supports the hypothesis that the observed Allele-Specific Expression is due to differences in the *cis*-regulatory promoter elements.", "answer": "$$\\boxed{3.78}$$", "id": "1489206"}]}